Metformin vs Semaglutide: Which Is Better for Weight Loss in

Metformin has been the go-to diabetes and weight management medication for decades. Semaglutide (Ozempic, Wegovy) is the new blockbuster on the block. If you’re weighing your options, this head-to-head breakdown covers everything you need to know for 2026.

Metformin vs Semaglutide: Quick Comparison

Factor	Metformin	Semaglutide (Wegovy/Ozempic)
Drug class	Biguanide	GLP-1 receptor agonist
FDA approval	Type 2 diabetes (1994)	Diabetes (2017), Obesity (2021)
Average weight loss	2–5 lbs	15–35 lbs
Mechanism	Reduces liver glucose output	Suppresses appetite, slows gastric emptying
Dosing	Oral, 1–3x daily	Weekly injection or daily pill (Rybelsus)
Monthly cost (retail)	$10–$30 (generic)	$900–$1,350
Insurance coverage	Almost universal	Often requires PA; variable
Side effects	GI upset, B12 depletion	Nausea, vomiting, constipation
Cardiovascular benefit	Modest (UKPDS data)	Strong (SELECT trial: 20% MACE reduction)
Best for	T2D, PCOS, budget-conscious	Significant weight loss, cardiovascular risk

How Each Drug Works

Metformin: The Metabolic Workhorse

Metformin works primarily by inhibiting hepatic glucose production — it tells your liver to stop dumping glucose into your bloodstream. It also modestly improves insulin sensitivity in muscle tissue and may influence the gut microbiome. It doesn’t directly suppress appetite or affect hunger hormones like GLP-1 medications do.

Semaglutide: The Appetite Suppressor

Semaglutide mimics GLP-1, a hormone your gut releases after eating. It signals your brain that you’re full, dramatically slows how fast food leaves your stomach, and reduces the reward response to food. This is why people on semaglutide often report simply not thinking about food — not just willpower, but actual neurochemical change.

Weight Loss: The Numbers Don’t Lie

The weight loss difference between metformin and semaglutide is substantial. In clinical trials:

Trial	Drug	Duration	Average Weight Loss
UKPDS (subset)	Metformin	10 years	~2–5 lbs
STEP 1	Semaglutide 2.4mg	68 weeks	14.9% body weight (~34 lbs)
STEP 2 (T2D patients)	Semaglutide 1mg	68 weeks	9.6% body weight
SELECT (cardiovascular)	Semaglutide 2.4mg	~3.3 years	9.4% body weight

Metformin’s weight loss effects are mild and largely secondary to its glycemic benefits. Semaglutide’s effects are primary — weight loss is the mechanism, not just a side effect.

Who Should Choose Metformin?

Metformin remains a strong choice for several groups. If you have type 2 diabetes and insurance limitations, metformin’s near-universal generic coverage at $10–$30/month is hard to beat. It’s also first-line for PCOS (polycystic ovary syndrome) due to its effect on insulin resistance, and has decades of long-term safety data. People with B12 deficiency should monitor levels, as metformin can impair absorption over time.

Who Should Choose Semaglutide?

Semaglutide is the better choice if your primary goal is meaningful weight loss (15%+ of body weight), you have established cardiovascular disease (the SELECT trial shows real mortality benefit), or you’ve tried metformin and seen minimal weight change. It’s also increasingly preferred for PCOS when metformin hasn’t been effective enough. The barrier is cost and insurance access.

Can You Take Both Together?

Yes — and this is actually a common combination. Many patients with type 2 diabetes take metformin as their baseline medication and add semaglutide for enhanced glucose control and weight loss. The drugs work through entirely different mechanisms, so there’s no interaction risk. Some studies suggest metformin may also reduce the GI side effects of GLP-1 medications, though evidence is limited.

Cost and Insurance Realities in 2026

This is where metformin wins hands-down. Generic metformin costs under $30/month at virtually any pharmacy. Semaglutide (as Wegovy or Ozempic) costs $900–$1,350/month retail without insurance. Most commercial plans cover Ozempic for diabetes more readily than Wegovy for obesity. Novo Nordisk’s savings programs can reduce costs to as low as $0/month for eligible commercially insured patients. Medicare does not cover Wegovy for obesity as of early 2026, though legislation is pending.

Side Effect Comparison

Side Effect	Metformin	Semaglutide
Nausea	Common (especially at start)	Very common (30–40%)
Diarrhea	Common	Less common
Constipation	Rare	Common
Hypoglycemia	Low risk (alone)	Low risk (alone)
B12 deficiency	Yes (long-term)	No
Thyroid risk	None	Black box (MTC) — theoretical in humans
Pancreatitis	No link	Rare, possible association
Lactic acidosis	Rare but serious	None

The Bottom Line

If you want affordable, well-studied, and solid metabolic support — metformin is still a cornerstone medication. If you want transformative weight loss with cardiovascular benefits and can navigate the cost/insurance hurdle — semaglutide is in a different league. Many patients end up on both, using metformin as a foundation and semaglutide as the heavy lifter.

The best starting point: talk to a telehealth GLP-1 provider who can evaluate your full metabolic picture and recommend the right approach for your goals and budget.

Frequently Asked Questions

Is metformin a GLP-1 drug?
No. Metformin is a biguanide that works primarily on the liver. GLP-1 drugs like semaglutide mimic the GLP-1 gut hormone to suppress appetite and slow gastric emptying — a completely different mechanism.

Can metformin cause weight loss like semaglutide?
Not to the same degree. Metformin typically produces 2–5 lbs of weight loss. Semaglutide produces 15–35 lbs on average in clinical trials.

Which is better for PCOS — metformin or semaglutide?
Both are used, and both address insulin resistance. Metformin is typically tried first due to its long track record and low cost. Semaglutide is increasingly prescribed when metformin alone isn’t achieving adequate results.

Is it safe to take metformin and semaglutide at the same time?
Yes. These drugs work through different mechanisms and are commonly prescribed together for type 2 diabetes patients who also need weight management support.